Reason for request
Inscription
Clinical Benefit
| Substantial |
Le service médical rendu par PROPOFOL PANPHARMA 10 mg/mL et 20 mg/mL en émulsion injectable (IV) est important dans les indications de l’AMM.
|
Clinical Added Value
| no clinical added value |
Ces deux spécialités, génériques de DIPRIVAN, n’apportent pas d’amélioration du service médical rendu (ASMR V, inexistante).
|
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
78wjU3HdJ4qZtnGP